Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid Arthritis.
Josephine A M P AmkreutzEmma C de MoelLisa TheanderMinna WillimLotte HeimansJan-Åke NilssonMagnus K KarlssonThomas Wj HuizingaKristina E ÅkessonLennart T H JacobssonCornelia F AllaartCarl TuressonDiane van der WoudePublished in: Arthritis & rheumatology (Hoboken, N.J.) (2021)
The presence of ACPAs is associated with significantly lower BMD at baseline, but not with greater BMD loss over time in treated RA patients. These results suggest that ACPAs alone do not appear to contribute to bone loss after disease onset when disease activity is well-managed.
Keyphrases
- disease activity
- bone mineral density
- systemic lupus erythematosus
- rheumatoid arthritis
- bone loss
- postmenopausal women
- newly diagnosed
- ankylosing spondylitis
- rheumatoid arthritis patients
- end stage renal disease
- body composition
- ejection fraction
- juvenile idiopathic arthritis
- prognostic factors
- patient reported outcomes